UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
We compare which structure offers superior tax efficiency between dividend ETFs and taxable funds, focusing on after-tax returns and fees.
28,247 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Twilio stocks have seen a pullback after a strong run. This guide explains how to assess whether you should twilio di...
Gen Z is saving record rates driven by auto-enrollment and digital tools, yet Beth Kobliner warns a single habit coul...
A casual NYC walk can ignite dating chatter that reaches far beyond tabloids. This article breaks down the financial ...
Oracle just posted its strongest quarter ever with massive cloud backlog, yet investors face a capital-heavy path ahe...
Mega-cap AI bets are fueling a surge in debt issuance this year, prompting fresh debate over whether the AI expansion...
Meta’s latest move signals a serious push into cloud services. This article breaks down what Mark Zuckerberg's Meta l...
Stellantis unveiled a bold €60 billion turnaround plan at Investor Day, aiming to reshape costs, cash flow, and a mod...
Online chatter can threaten more than reputations; it can touch family budgets and financial security. This piece exp...
Gas prices are reshaping how Americans travel. This article explains the surge in carpooling, highlights a stock buil...
NVIDIA has redefined its role in the AI era, but the upside isn’t finished. This piece unpack three practical reasons...
What could SpaceX stock be worth by the end of 2026? This thoughtful guide weighs base, bullish, and bearish cases, p...